Oral Curcumin (Meriva) Is Effective as an Adjuvant Treatment and Is Able to Reduce IL-22 Serum Levels in Patients with Psoriasis Vulgaris

Table 1

Baseline demographic information of the participants.

	Arm 1 ()	Arm 2 ()
Sex	14 M, 17 F	18 M, 14 F
Age (median, range)	37 (19–62)	41 (22–59)
Race	30 Caucasian; 1 Hispanic	32 Caucasian
Onset age (median, range)	31 (14–54)	35 (20–51)